መነሻGRTSQ • OTCMKTS
Gritstone bio Inc
$0.0060
ጃን 13, 11:34:26 ጥዋት ጂ ኤም ቲ-5 · USD · OTCMKTS · ተጠያቂነትን ማንሳት
ክምችትበዩናይትድ ስቴትስ የተዘረዘረ ደህንነትዋና መስሪያ ቤቱ ዩናይትድ ስቴትስ ውስጥ የሆነ
የቀዳሚ መዝጊያ
$0.0066
የቀን ክልል
$0.0060 - $0.0065
የዓመት ክልል
$0.0029 - $3.17
የገበያው አጠቃላይ ዋጋ
464.17 ሺ USD
አማካይ መጠን
3.42 ሚ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
OTCMKTS
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(USD)ጁን 2024ከዓመት ዓመት ለውጥ
ገቢ
921.00 ሺ-52.89%
የሥራ ወጪ
7.70 ሚ14.62%
የተጣራ ገቢ
-23.40 ሚ33.64%
የተጣራ የትርፍ ክልል
-2.54 ሺ-40.86%
ገቢ በሼር
-0.1648.39%
EBITDA
-25.98 ሚ23.17%
ውጤታማ የግብር ተመን
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(USD)ጁን 2024ከዓመት ዓመት ለውጥ
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ
55.71 ሚ-51.36%
አጠቃላይ ንብረቶች
142.54 ሚ-35.97%
አጠቃላይ ተጠያቂነቶች
120.35 ሚ6.45%
አጠቃላይ እሴት
22.19 ሚ
የሼሮቹ ብዛት
118.11 ሚ
የገበያ ዋጋ እና የተገለጸ ዋጋ
0.03
የእሴቶች ተመላሽ
-49.31%
የካፒታል ተመላሽ
-57.02%
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(USD)ጁን 2024ከዓመት ዓመት ለውጥ
የተጣራ ገቢ
-23.40 ሚ33.64%
ከክወናዎች የተገኘ ጥሬ ገንዘብ
-26.81 ሚ13.41%
ገንዘብ ከኢንቨስትመንት
-885.00 ሺ-103.60%
ገንዘብ ከፋይናንስ
35.63 ሚ3,403.74%
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
7.94 ሚ248.24%
ነፃ የገንዘብ ፍሰት
-14.40 ሚ32.03%
ስለ
Gritstone bio was a clinical-stage American biotechnology company which attempted to develop cancer and infectious disease immunotherapies and vaccines. It was founded in August 2015 as Gritstone Oncology, Inc., with offices in Emeryville, California. In September 2021 it raised $55.0 million from the sale of 5,000,000 shares. It started a Phase 1 trial of its self-amplifying mRNA second generation SARS-CoV-2 vaccine, GRT-R910, in the NIHCR Manchester Clinical Research Facility at Manchester Royal Infirmary, in September 2021. This is to explore the ability of GRT-R910 to boost and expand the immunogenicity of AstraZeneca's first-generation COVID-19 vaccine AZD1222 in healthy adults of more than 60 years. It uses lipid nanoparticles to deliver a broad set of antigens against SARS-CoV-2 that includes both stabilized spike protein and highly conserved viral protein regions containing T cell epitopes. Prof. Andrew Ustianowski is the study’s chief investigator. On 10 November 2021, Gritstone announced positive preclinical data of its second-generation self-amplifying mRNA vaccine against SARS-CoV-2 in non-human primate models. Wikipedia
የተመሰረተው
ኦገስ 2015
ድህረገፅ
ሠራተኞች
231
ፍለጋ
ፍለጋ አጽዳ
ፍለጋን ዝጋ
Google መተግበሪያዎች
ዋናው ምናሌ